HL-21

N/A

Report date: 2023/09/14 17:50:47

Base Information

Drug NameHL-21

Drug Alias NameHL-21

ClassificationSmall molecules

Mechanisms of ActionSARS-CoV-2 PLpro inhibitors

TargetsSARS-CoV-2 papain-like protease

Therapy Area/IndicationsCoronavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesTsinghua University

China Registration ClassN/A

Develop Information

Active CompaniesTsinghua University

Inactive CompaniesN/A

Active IndicationsCoronavirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A